{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:40:58Z","timestamp":1792597258173,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.bbrc.2015.03.038","type":"journal-article","created":{"date-parts":[[2015,3,14]],"date-time":"2015-03-14T20:00:26Z","timestamp":1426363226000},"page":"354-361","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["MicroRNA-224 targets ERG2 and contributes to malignant progressions of meningioma"],"prefix":"10.1016","volume":"460","author":[{"given":"Maomao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingyan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2015.03.038_bib1","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s11910-013-0337-4","article-title":"Meningioma","volume":"13","author":"Fathi","year":"2013","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.bbrc.2015.03.038_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuchi.2014.05.006","article-title":"Epidemiology of meningiomas","author":"Baldi","year":"2014","journal-title":"Neurochirurgie"},{"key":"10.1016\/j.bbrc.2015.03.038_bib3","doi-asserted-by":"crossref","first-page":"E5","DOI":"10.3171\/2013.10.FOCUS13360","article-title":"A\u00a0review of epigenetic and gene expression alterations associated with intracranial meningiomas","volume":"35","author":"He","year":"2013","journal-title":"Neurosurg. Focus"},{"key":"10.1016\/j.bbrc.2015.03.038_bib4","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/CCO.0b013e3283571a06","article-title":"New insights into meningioma: from genetics to trials","volume":"24","author":"Vranic","year":"2011","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.bbrc.2015.03.038_bib5","doi-asserted-by":"crossref","first-page":"E4","DOI":"10.3171\/2013.8.FOCUS13305","article-title":"Current standing and frontiers of gene therapy for meningiomas","volume":"35","author":"De La Garza-Ramos","year":"2013","journal-title":"Neurosurg. Focus"},{"key":"10.1016\/j.bbrc.2015.03.038_bib6","doi-asserted-by":"crossref","first-page":"730","DOI":"10.5306\/wjco.v5.i4.730","article-title":"MicroRNAs in cancer therapeutic response: friend and foe","volume":"5","author":"Xue","year":"2014","journal-title":"World J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.bbrc.2015.03.038_bib7","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1136\/gutjnl-2014-307891","article-title":"MicroRNAs: new players in IBD","volume":"64","author":"Kalla","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.bbrc.2015.03.038_bib8","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.addr.2014.09.002","article-title":"Small molecule compounds targeting miRNAs for cancer therapy","volume":"81C","author":"Monroig","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bbrc.2015.03.038_bib9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.addr.2014.09.001","article-title":"Circulating miRNAs: roles in cancer diagnosis, prognosis and therapy","volume":"81C","author":"Cheng","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bbrc.2015.03.038_bib10","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3892\/ol.2012.742","article-title":"miR-224 functions as an onco-miRNA in hepatocellular carcinoma cells by activating AKT signaling","volume":"4","author":"Ma","year":"2012","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbrc.2015.03.038_bib11","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.humpath.2014.10.027","article-title":"Dysregulated microRNA-224\/apelin axis associated with aggressive progression and poor prognosis in patients with prostate cancer","volume":"46","author":"Wan","year":"2015","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.bbrc.2015.03.038_bib12","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.3892\/or.2014.3311","article-title":"Expression of miR-224-5p is associated with the original cisplatin resistance of ovarian papillary serous carcinoma","volume":"32","author":"Zhao","year":"2014","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbrc.2015.03.038_bib13","article-title":"MicroRNA-224 and its target CAMKK2 synergistically influence tumor progression and patient prognosis in prostate cancer","author":"Fu","year":"2014","journal-title":"Tumour Biol."},{"key":"10.1016\/j.bbrc.2015.03.038_bib14","doi-asserted-by":"crossref","first-page":"13205","DOI":"10.1074\/jbc.M707629200","article-title":"Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target","volume":"283","author":"Wang","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2015.03.038_bib15","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2217\/epi.11.5","article-title":"Role of miR-224 in hepatocellular carcinoma: a tool for possible therapeutic intervention?","volume":"3","author":"Wang","year":"2011","journal-title":"Epigenomics"},{"key":"10.1016\/j.bbrc.2015.03.038_bib16","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/carcin\/bgs401","article-title":"RLIP76 is overexpressed in human glioblastomas and is required for proliferation, tumorigenesis and suppression of apoptosis","volume":"34","author":"Wang","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbrc.2015.03.038_bib17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s11060-013-1045-2","article-title":"Knockdown of RLIP76 expression by RNA interference inhibits invasion, induces cell cycle arrest, and increases chemosensitivity to the anticancer drug temozolomide in glioma cells","volume":"112","author":"Wang","year":"2013","journal-title":"J.\u00a0Neurooncol."},{"key":"10.1016\/j.bbrc.2015.03.038_bib18","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.leukres.2008.11.012","article-title":"Epigenetic control of differential expression of specific ERG isoforms in acute T-lymphoblastic leukemia","volume":"33","author":"Bohne","year":"2009","journal-title":"Leuk. Res."},{"key":"10.1016\/j.bbrc.2015.03.038_bib19","first-page":"1423","article-title":"Human ERG is a proto-oncogene with mitogenic and transforming activity","volume":"10","author":"Hart","year":"1995","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2015.03.038_bib20","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1038\/sj.onc.1206222","article-title":"EGR2 induces apoptosis in various cancer cell lines by direct transactivation of BNIP3L and BAK","volume":"22","author":"Unoki","year":"2003","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.bbrc.2015.03.038_bib21","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.prp.2014.11.002","article-title":"WHO grade related expression of TRAIL-receptors and apoptosis regulators in meningioma","volume":"211","author":"Koschny","year":"2014","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.bbrc.2015.03.038_bib22","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.cell.2009.02.005","article-title":"MicroRNAs and cancer: short RNAs go a long way","volume":"136","author":"Ventura","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2015.03.038_bib23","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1038\/bjc.2014.551","article-title":"MiR-224 promotes the chemoresistance of human lung adenocarcinoma cells to cisplatin via regulating G1\/S transition and apoptosis by targeting p21WAF1\/CIP1","volume":"111","author":"Wang","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbrc.2015.03.038_bib24","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1210\/me.2009-0432","article-title":"MicroRNA-224 is involved in transforming growth factor-beta-mediated mouse granulosa cell proliferation and granulosa cell function by targeting Smad4","volume":"24","author":"Yao","year":"2010","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.bbrc.2015.03.038_bib25","doi-asserted-by":"crossref","first-page":"4272","DOI":"10.1038\/onc.2009.278","article-title":"Regulation of miRNA expression by Src and contact normalization: effects on nonanchored cell growth and migration","volume":"28","author":"Li","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2015.03.038_bib26","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3892\/or.2014.3614","article-title":"Clinical significance of microRNA-21 as a biomarker in each Dukes' stage of colorectal cancer","volume":"33","author":"Fukushima","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbrc.2015.03.038_bib27","doi-asserted-by":"crossref","first-page":"e109347","DOI":"10.1371\/journal.pone.0109347","article-title":"Association of serum microRNA expression in hepatocellular carcinomas treated with transarterial chemoembolization and patient survival","volume":"9","author":"Liu","year":"2014","journal-title":"PLoS One"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X15004738?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X15004738?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T20:52:34Z","timestamp":1566420754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X15004738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0006291X15004738"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2015.03.038","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MicroRNA-224 targets ERG2 and contributes to malignant progressions of meningioma","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2015.03.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}